Lombard Odier Asset Management Switzerland SA Boosts Stock Holdings in MetLife, Inc. $MET

Lombard Odier Asset Management Switzerland SA lifted its holdings in MetLife, Inc. (NYSE:MET) by 126.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 81,086 shares of the financial services provider’s stock after purchasing an additional 45,300 shares during the period. Lombard Odier Asset Management Switzerland SA’s holdings in MetLife were worth $6,401,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Activest Wealth Management increased its stake in shares of MetLife by 205.8% in the 4th quarter. Activest Wealth Management now owns 315 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 212 shares in the last quarter. Vermillion & White Wealth Management Group LLC increased its stake in shares of MetLife by 790.0% in the 3rd quarter. Vermillion & White Wealth Management Group LLC now owns 356 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 316 shares in the last quarter. Sound Income Strategies LLC increased its stake in shares of MetLife by 58.9% in the 4th quarter. Sound Income Strategies LLC now owns 383 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 142 shares in the last quarter. Foster Dykema Cabot & Partners LLC purchased a new stake in MetLife in the 3rd quarter worth $32,000. Finally, Albion Financial Group UT purchased a new stake in MetLife in the 4th quarter worth $32,000. Hedge funds and other institutional investors own 94.99% of the company’s stock.

MetLife Price Performance

MetLife stock opened at $87.33 on Wednesday. MetLife, Inc. has a 52-week low of $67.33 and a 52-week high of $89.62. The firm has a market capitalization of $56.19 billion, a price-to-earnings ratio of 16.92, a PEG ratio of 0.66 and a beta of 0.78. The company has a fifty day simple moving average of $80.22 and a 200-day simple moving average of $77.58. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.53.

MetLife (NYSE:MET) last released its earnings results on Wednesday, May 6th. The financial services provider reported $2.42 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.27 by $0.15. MetLife had a net margin of 4.66% and a return on equity of 22.60%. The business had revenue of $14.18 billion during the quarter, compared to analyst estimates of $19.49 billion. During the same quarter in the prior year, the firm earned $1.96 earnings per share. The company’s revenue for the quarter was up 2.7% compared to the same quarter last year. On average, equities analysts anticipate that MetLife, Inc. will post 9.98 EPS for the current fiscal year.

MetLife Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 9th. Stockholders of record on Tuesday, May 12th were given a $0.5925 dividend. This represents a $2.37 dividend on an annualized basis and a dividend yield of 2.7%. This is a boost from MetLife’s previous quarterly dividend of $0.57. The ex-dividend date was Tuesday, May 12th. MetLife’s dividend payout ratio (DPR) is currently 45.93%.

Analyst Upgrades and Downgrades

Several brokerages recently commented on MET. Evercore set a $96.00 price target on shares of MetLife in a report on Thursday, April 9th. Wells Fargo & Company boosted their price target on shares of MetLife from $90.00 to $95.00 and gave the stock an “overweight” rating in a report on Tuesday, May 12th. Mizuho set a $95.00 price target on shares of MetLife in a report on Friday, May 8th. Keefe, Bruyette & Woods boosted their price objective on MetLife from $87.00 to $98.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 13th. Finally, Piper Sandler boosted their price objective on MetLife from $81.00 to $86.00 and gave the stock a “neutral” rating in a research note on Tuesday, May 26th. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $95.31.

MetLife Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.